Drug Topics

NOVEMBER 20, 2023

Rich in polyphenolic compounds like chlorogenic acid (CGA), coffee may help ward off COVID-19 infection in the post-pandemic era.

Compounding 187

Compounding 187

Pharmacy Times

NOVEMBER 20, 2023

The results suggest that telemedicine could be used to help improve access for other populations that might be stigmatized, beyond hepatitis C virus and opioid use disorder.

153

153

STAT

NOVEMBER 20, 2023

In the depths of the Covid-19 pandemic, something strange happened: For a year or two, illnesses that used to emerge like clockwork when fall and winter arrived — flu, RSV, and the myriad viruses that cause colds — did not sicken us. The cause now appears clear: The measures we took to avoid the new disease, including isolating and social distancing, muscled most other respiratory pathogens out of the cold-and-flu-season picture.

145

145

Pharmacy Times

NOVEMBER 20, 2023

Despite patients and clinicians preferring in-person consultations, most patients reported that clinicians answered all questions and effectively resolved issues during remote consultations.

132

132

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

NOVEMBER 20, 2023

Cell and gene therapies are the next frontier in medicine and promise long-sought hope for people living with incurable and fatal conditions. As their promise increasingly becomes reality, the FDA’s gatekeeping role is important. To truly serve the people who need these medications, the FDA must be a good-faith partner and deploy the tools my fellow congressional lawmakers and I helped secure.

FDA 144

FDA 144

Pharmacy Times

NOVEMBER 20, 2023

Mice with human breast cancer tissue and high levels of the Myc cancer-driving gene who received a vitamin B5-deficient diet had slower tumor growth.

145

145

Pharmacy Times

NOVEMBER 20, 2023

Improvements were seen in left ventricular ejection fraction, NYHA Functional Class, and Minnesota Living with Heart Failure Questionnaire at 1-year post-dose.

139

139

Fierce Healthcare

NOVEMBER 20, 2023

Traditional Medicare paid out an estimated $31.2 billion in improper payments in fiscal year 2023, according to new data from the federal government. | The Centers for Medicare & Medicaid Services released its annual look at improper payments and found that the overall rate in Medicare was 7.38%, which sits below the 10% level mandated in statute.

131

131

STAT

NOVEMBER 20, 2023

Health systems whose budgets were squeezed dry during the pandemic are creeping back into the black, but they’re far from the days when they had cash to blow on flashy tech pilots that might never pan out. Instead, hospital leaders are increasingly cautious about their spending and the technology they test out, insisting that new products demonstrate concrete, measurable benefits to patients without disrupting an already fatigued clinical workforce — a marked difference from the pr

Hospitals 125

Hospitals 125

Pharmacy Times

NOVEMBER 20, 2023

The study authors suggest that future research should instead emphasize event rates and patient-reported outcomes to better evaluate the tolerability and frequency of AEs.

123

123

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

NOVEMBER 20, 2023

Whether you’re a fan of the drug name Zepbound or, like one X user , think it sounds like “an off brand bus line,” you’re likely to have some opinion about the new moniker for Eli Lilly’s blockbuster diabetes drug Mounjaro. The company announced the new name on Nov. 8 following the Food and Drug Administration’s approval of the drug for weight loss as well.

129

129

Fierce Pharma

NOVEMBER 20, 2023

After blasting the U.K.’s drug pricing policy, the pharma industry has secured a new government spending deal featuring a higher revenue cap and an innovative drug-friendly rebate mechanism. | After blasting the U.K.’s drug pricing policy, the pharma industry has secured an improved government spending deal. The agreement will double the annual growth rate for prescription meds over the coming years.

124

124

Drug Topics

NOVEMBER 20, 2023

Drug Topics recently sat down with Steve Hoffart, PharmD, owner and PIC at Magnolia Pharmacy north of Houston, to discuss the importance of pharmacists getting involved in advocacy.

98

98

Fierce Pharma

NOVEMBER 20, 2023

“AI is becoming part of the pharma fabric, and it really is set to disrupt the industry.” | Viz.ai’s Nina Binetti is joined by colleagues at CrowdPharm and Remedy Product Studio to explore the various ways in which AI is being used among pharma companies – from improving patient diagnoses and treatments to unlocking operating efficiencies.

120

120

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Drug Topics

NOVEMBER 20, 2023

The FDA approval marks an important public health milestone in the ongoing effort to empower patients to take control of their own health.

FDA 112

FDA 112

STAT

NOVEMBER 20, 2023

LONDON — The U.K. and the pharmaceutical industry have reached a deal on a five-year plan outlining how the health system pays for drugs, as the country tries to keep a lid on its medicines spending while simultaneously building up its life sciences industry. The plan, which goes into effect next year, was announced Monday in a joint statement from the government, England’s National Health Service, and the Association of the British Pharmaceutical Industry.

117

117

Fierce Pharma

NOVEMBER 20, 2023

The threat of microbial contamination has triggered yet another drug recall, this time from German pharma bigwig Bayer. | Bayer is recalling one lot of Vitrakvi oral solution in the U.S. after routine stability testing discovered the presence of microbial contamination identified as Penicillium brevicompactum.

117

117

The Checkup by Singlecare

NOVEMBER 20, 2023

Seasonal allergies are commonly associated with spring, but summer and fall can also trigger allergy symptoms. Also known as hay fever or allergic rhinitis, seasonal allergies can cause symptoms like sneezing, a runny nose, and itchy, watery eyes. No matter how often your allergies flare up, you don’t have to live with the symptoms as there are many effective treatments, including eye drops, shots, and oral medications.

Mayo Clinic 113

Mayo Clinic Immunization FDA 113

Fierce Pharma

NOVEMBER 20, 2023

It appears Bristol Myers Squibb’s multiple myeloma cell therapy Abecma will not end the year on a happy note. | It appears Bristol Myers Squibb’s multiple myeloma cell therapy Abecma will not end the year on a happy note. The company’s effort to gain approval for the CAR-T in an earlier line of treatment—previously set for an FDA decision on Dec. 16—will have to be pushed back pending an advisory committee meeting.

FDA 114

FDA 114

STAT

NOVEMBER 20, 2023

Good morning and welcome to Thanksgiving week! STAT reporter Andrew Joseph here filling in for Mr. Pharmalot today. It’s my first Thanksgiving since moving over to London to expand STAT’s European coverage, but never fear, a Thanksgiving feast will be had on Thursday. (A reminder: It’s not too early to get started on some prep. I made my pie crusts over the weekend and they will hang in the freezer for a few days.

103

103

The Guardian - Pharmaceutical Industry

NOVEMBER 20, 2023

People should not die because of their income or where they were born. We must have the courage to stand up to the pharmaceutical industry Here is a simple moral proposition. No one in America, or anywhere in the world, should die or suffer unnecessarily because they cannot afford a prescription drug which, in many cases, costs a few cents or a few dollars to manufacture.

111

111

pharmaphorum

NOVEMBER 20, 2023

The European Commission has approved Almirall’s lebrikizumab as Ebglyss for the treatment of moderate-to-severe atopic dermatitis (AD), with an EU rollout set to start in Germany next year.

FDA 105

FDA 105

The Checkup by Singlecare

NOVEMBER 20, 2023

Most of us have been there, but it’s still no fun to wake up with our heads throbbing after a big night out. Hangovers, one symptom of which is headaches, are caused and exacerbated by a handful of factors associated with excessive alcohol consumption. A 2015 study published in the Experimental and Clinical Psychopharmacology journal found that hangovers affect 75% of the general population after moderate alcohol consumption.

Compounding 105

Compounding 105

Digital Pharmacist

NOVEMBER 20, 2023

The holiday season is upon us, and with this time of year comes an influx of pharmacy calls. As patients seek medication refills before they travel and inquire about vaccinations before their holiday gatherings, it’s crucial for pharmacies to optimize their Interactive Voice Response (IVR) systems. A well-thought-out IVR menu and efficient call routing can significantly enhance the customer experience and streamline operations during the busy holiday period.

Health and Personal Care Stores 105

Health and Personal Care Stores Vaccines Communication 105

PharmaVoice

NOVEMBER 20, 2023

Biohaven and other companies are aiming to develop meds with a different mechanism of action that trim the waistline while building lean tissue.

111

111

Fierce Pharma

NOVEMBER 20, 2023

Thanks to a new FDA approval, patients with ultra-rare desmoid tumors now have an FDA-approved treatment. | Patients with ultra-rare desmoid tumors now have an FDA-approved treatment, thanks to a drug made by SpringWorks Therapeutics, which spun out of Pfizer in 2017 with a portfolio of rare disease candidates.

FDA 97

FDA 97

Pharmaceutical Technology

NOVEMBER 20, 2023

Takhzyro has been approved for the routine prevention of recurrent hereditary angioedema attacks in patients aged 2 years and older.

111

111

Pharmacy Times

NOVEMBER 20, 2023

Patient sues pharmacy citing communication gaps after prescription was located

Communication 130

Communication 130

European Pharmaceutical Review

NOVEMBER 20, 2023

Eli Lilly and Company has announced that it plans to construct a new $2.5 billion parenteral (injectable) manufacturing site in Alzey, Rhineland-Palatinate, Germany. Supporting European parenteral manufacture and supply Alongside expanding the company’s global parenteral product and device manufacturing network, the new facility will support the higher demand for Eli Lilly’s medicines, including its diabetes and obesity portfolio.

90

90

Pharmaceutical Technology

NOVEMBER 20, 2023

The value of haemophilia gene therapies like Roctavian and Hemgenix hinge on long-term efficacy and innovative payment structures play a key role.

98

98

Fierce Healthcare

NOVEMBER 20, 2023

Digital staffing company Aya Healthcare acquired Winnow AI to bolster its physician recruitment capabilities as the industry grapples with a historic provider shortage. | It marks Aya Healthcare's third M&A deal in five months as the company works to build up its artificial intelligence capabilities for staffing, hiring and retention.

84

84

Drug Topics

NOVEMBER 20, 2023

The capsule was developed by the pharmaceutical company Lupin and is a generic equivalent to Boehringer Ingelheim’s Spiriva HandiHaler.

Pharmaceutical Companies 86

Pharmaceutical Companies Pharmaceutical Companies 86

Pharmaceutical Technology

NOVEMBER 20, 2023

AstraZeneca has launched a new digital health solutions business, Evinova, to expedite innovation in the life sciences industry.

100

100

European Pharmaceutical Review

NOVEMBER 20, 2023

On World Antibiotic Awareness Week (WAAW), 18-24 November 2023, the European Federation of Pharmaceutical Industries and Associations (EFPIA) has highlighted the importance of efficient legislation for determining the EU’s future actions in the challenge to overcome antimicrobial resistance (AMR). The trade association for Europe’s pharmaceutical industry urged in a statement that in facing the threat of AMR, a “comprehensive approach, encompassing enhanced surveillance, prudent use, preventive

Vaccines 82

Vaccines 82